HighField Bio
  • Home
  • Oncology
    • Oncology Pipeline
    • LipoADC™ Platform – K1
    • TRAFsome™ T cell Engager – HF50
    • Immune Modulator – K16
  • Gene Therapy
    • Gene Therapy Pipeline
    • HFG1
  • Facilities
  • About
  • News & Publications
  • Contact
HighField Bio
  • Home
  • Oncology
    • Oncology Pipeline
    • LipoADC™ Platform – K1
    • TRAFsome™ T cell Engager – HF50
    • Immune Modulator – K16
  • Gene Therapy
    • Gene Therapy Pipeline
    • HFG1
  • Facilities
  • About
  • News & Publications
  • Contact

Search Posts

About Us

Lorem ipsum dolor sit amet, consectetur adipisc
glelit, sed do eiusmod tempor incididunt .ut labo
et dolore magna aliqua.

Blog Categories

  • HighField in the News (3)
  • Press Release (11)
  • Publications (14)
  • References (21)
  • Uncategorized (6)

Recent Posts

Post placeholder image
September 4, 2024

HighField Biopharmaceuticals Company Profile – 2024

by PJWCreative
Post placeholder image
September 3, 2024

HighField Biopharmaceuticals Files IND in China for Clinical Trial of HF50, a Unique Lipid-Based T Cell Engager, to Treat Solid Tumor Cancers

by PJWCreative
Post placeholder image
August 8, 2024

ASCO Breakthrough 2024 Poster: Exploratory phase I study of HF1K16 for the treatment of patients with refractory/recurrent advanced glioma

by PJWCreative
Post placeholder image
June 24, 2024

HighField Biopharmaceuticals’ mRNA-based HFG1 Demonstrates Potential as a Longer Acting GLP-1R Agonist for Diabetic Control and Weight Loss

by PJWCreative
Post placeholder image
June 21, 2024

American Diabetes Association 2024 Poster: Preliminary study of efficacy and duration of an mRNA based GLP-1R agonist in diabetic monkeys

by HighField Bio
May 28, 2024

HighField Biopharmaceuticals ASCO 2024 Poster Presentation Shows HFK1, a Unique Immunoliposome May Improve Clinical Outcomes over Antibody Drug Conjugates

by PJWCreative

Recent Comments

No comments to show.

Tags

General HF50 HFG1 K1 K16

Post placeholder image
September 3, 2020 in Publications

When liposomes met antibodies: Drug delivery and beyond

PJWCreative 0 Like Post 0 Comment
Read More

Home
Technology
Pipeline
Facilities
About
News & Publications

Contact Us

Follow Us

Linkedin Weixin
HIGHfield_logo_horizontal_FINAL_trans

Home
Technology
Pipeline
Facilities
About
News & Publications

Contact Us

Follow Us

HIGHFIELD_web_LI_icon_x75

© 2024 HighField Biopharmaceuticals, Inc.   Terms of Use.       
LipoADCplex™ and TRAFsome™ are trademarks of HighField Biopharmaceuticals, Inc